v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net loss $ (3,069) $ (19,343)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization 771 434
Amortization of debt discount 277 334
Change in fair value of derivatives (9,416) (1,280)
Change in fair value of share payable (201) 23
Change in fair value of convertible notes (5,235) (3,697)
Loss from extinguishment of debt 4,756 7,282
Loss from issuance of debt 738  
Inducement expense 87  
Amortization of operating lease right-of-use asset 76 64
Stock-based compensation for services 288 385
Allowance for credit loss 311  
Subtotal of non-cash charges (7,548) 3,545
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (2,276) 2
Other non-current assets 2 2
Accounts payable and accrued expenses 886 4,375
Related party accounts payable and accrued expenses (364) 2,020
Lease liabilities (140) (19)
Net cash used in operating activities (12,509) (9,418)
Cash Flows from Investing Activities:    
Purchase of equipment and construction in progress (129) (93)
Net cash used in investing activities (129) (93)
Cash Flows from Financing Activities:    
Proceeds from issuance of common shares 2,900 5,123
Proceeds from exercise of warrants 6 17
Proceeds from issuance of notes payable, net   5,000
Proceeds from issuance of convertible notes payable, net 7,469 2,200
Repayment of notes payable   (71)
Repayment of convertible notes payable (500) (536)
Payment of purchase consideration to related party (666)  
Net cash provided by financing activities 9,209 11,733
Effect of exchange rate changes on cash and cash equivalents 2,175 (1,618)
Net (decrease) increase in cash and cash equivalents (1,254) 604
Cash and cash equivalents, beginning of the period 3,040 2,175
Cash and cash equivalents, end of the period 1,786 2,779
Supplemental schedule of non-cash activities:    
Issuance of common stock for conversion of debt and accrued interest 8,889 9,604
Series C convertible preferred stock conversions 226 866
Capital expenditures included in accounts payable 34 171
Deemed dividend related to warrant modifications 331 265
Notes payable    
Supplemental disclosure of cash flow information    
Interest payments   $ (89)
Convertible notes payable    
Supplemental disclosure of cash flow information    
Interest payments $ (39)